MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$40,078K
Net Income
-$35,248K
Net Profit Margin
-87.95%
EPS
-$0.35
Unit: Thousand (K) dollars
Revenue Breakdown
Revenue-Product
Revenue-Copiktra License And Rel...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
40,078
18,671
7,729*
-
Cost of sales - product
3,762
2,772
1,150*
-
Cost of sales - intangible amortization
279
279
175*
-
Research and development
41,338
38,218
30,624*
-
Selling, general and administrative
27,409
22,299
20,287*
-
Revenue-Product
-
-
-
11,242
Total operating expenses
72,788
63,568
52,235*
-
Cost of sales - product
-
-
-
1,670
Loss from operations
-32,710
-44,897
-44,506*
-
Cost of sales - intangible amortization
-
-
-
290
Other expense
-52
-61
-51*
-
Research and development expenses
-
-
-
28,412
Interest income
1,108
1,297
1,017*
-
Commercial expenses
-
-
-
9,594
Medical affairs expenses
-
-
-
3,047
General and administrative expenses
-
-
-
6,764
Stock-based compensation expense
-
-
-
2,178
Depreciation expense
-
-
-
2
Interest expense
360
382
502*
-
Interest income
-
-
-
1,182
Loss on debt extinguishment
-
-
-456*
-
Interest expense
-
-
-
319
Change in fair value of warrant liability
-
-9,323
-25,849*
55,881
Change in fair value of notes
1,843
1,871
4,144*
2,748
Net loss before taxes
-33,857
-
-22,793
-
Other segment items
-
-
-
37
Income tax expense
816
-
-
-
Net loss
-34,673
-36,591
-22,793*
-98,518
Unrealized gain on available-for-sale securities
7
-7
-
-
Change in fair value of notes attributable to instrument specific credit risk
582
-3,396
912*
-2,745
Comprehensive loss
-35,248
-33,202
-23,705
-95,773
Basic EPS
-0.35
-0.37
-0.345
-1.35
Diluted EPS
-0.35
-0.46
-0.39
-1.35
Basic Average Shares
100,116,000
98,292,000
68,627,000
73,157,000
Diluted Average Shares
100,116,000
99,148,000
60,733,000
73,157,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$35,248K
(-43.37%↓ Y/Y)
Unrealized gain on
available-for-sale securities
$7K
Net loss
-$34,673K
(-33.70%↓ Y/Y)
Change in fair value of
notes attributable to...
$582K
(143.14%↑ Y/Y)
Net loss before
taxes
-$33,857K
Income tax expense
$816K
Interest income
$1,108K
Revenue-Product
$25,078K
Revenue-Copiktra License And
Related Assets
$15,000K
Loss from operations
-$32,710K
Change in fair value of
notes
$1,843K
(-38.36%↓ Y/Y)
Total revenue
$40,078K
Interest expense
$360K
(69.81%↑ Y/Y)
Other expense
-$52K
Total operating
expenses
$72,788K
Research and development
$41,338K
Selling, general and
administrative
$27,409K
Cost of sales -
product
$3,762K
Cost of sales -
intangible amortization
$279K
Buy us a coffee
Verastem, Inc. (VSTM)
Verastem, Inc. (VSTM)